Matthew Pfeffer - Second Sight Independent Director
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Director
Mr. Matthew J. Pfeffer, CPA., is Independent Director of the Company. Mr. Pfeffer served as Chief Executive Officer and Chief Financial Officer of MannKind Corporation from January 2016 to May 2017 and ceased being a director of that Company in October 2017. Previously, he served as the Corporationrationrate Vice President and Chief Financial Officer of MannKind Corporation from April 2008 until January 2016. Mr. Pfeffer served as Chief Financial Officer and Senior Vice President of Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, with responsibility for finance, tax, treasury, human resources, information technology, purchasing and facilities functions. Prior to VaxGen, Mr. Pfeffer served as Chief Financial Officer of Cell Genesys, Inc. During his nineyear tenure at Cell Genesys, Mr. Pfeffer served as Director of Finance before being named Chief Financial Officer in 1998. Prior to that, Mr. Pfeffer served in a variety of financial management positions at other companies, including roles as Corporationrationrate Controller, Manager of Internal Audit and Manager of Financial Reporting. Mr. Pfeffer began his career at Price Waterhouse. Mr. Pfeffer graduated from the University of California, Berkeley and is a Certified Public Accountant. Our board believes that Mr. Pfeffers executive and managerial experience together with his leadership skills make him well qualified to continue serving as one of our directors. since 2015.
| Age | 59 |
| Tenure | 9 years |
| Phone | 818 833-5000 |
| Web | www.secondsight.com |
Second Sight Management Efficiency
The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Greg OGorman | Ryanair Holdings PLC | N/A | |
| Richard Milliken | Ryanair Holdings PLC | 66 | |
| Kenneth Thompson | Alaska Air Group | 63 | |
| Charles McCreevy | Ryanair Holdings PLC | 67 | |
| Louise Phelan | Ryanair Holdings PLC | 50 | |
| Odelia Levanon | BOS Better Online | 51 | |
| Helvi Sandvik | Alaska Air Group | 66 | |
| Katherine Savitt | Alaska Air Group | 51 | |
| Raymond Johns | Air Transport Services | 63 | |
| Dhiren Fonseca | Alaska Air Group | 56 | |
| Mike OBrien | Ryanair Holdings PLC | 73 | |
| Declan McKeon | Ryanair Holdings PLC | 66 | |
| Roisin Brennan | Ryanair Holdings PLC | 53 | |
| Margaret Cannella | Townsquare Media | 63 | |
| John Teets | Air Transport Services | 45 | |
| Raymond Conner | Alaska Air Group | 65 | |
| B Ford | Townsquare Media | 52 | |
| Katherine SavittLennon | Alaska Air Group | 51 | |
| Gary Ginsberg | Townsquare Media | 58 | |
| David Lebow | Townsquare Media | 59 | |
| Marion Blakey | Alaska Air Group | 72 | |
Management Performance
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 |
Second Sight Medical Leadership Team
Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Blake, CFO | ||
| Patrick Ryan, COO | ||
| Frank Vandeputte, Vice President General Manager | ||
| Anthony Moses, Commercial Vice President - Americas | ||
| Edward Randolph, VP of Manufacturing | ||
| Gregg Williams, Independent Director | ||
| Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | ||
| Jonathan McGuire, President CEO, Director | ||
| Stephen Okland, Commercial Vice President U.S. and Canada | ||
| Gregoire Cosendai, VP of European Operations | ||
| Steven Okland, Commercial Vice President U.S. and Canada | ||
| William Link, Independent Director | ||
| Thomas Miller, CFO | ||
| James Miller, Director - Manufacturing | ||
| Will McGuire, President CEO, Director | ||
| David Jacques, Vice President - Research & Development | ||
| Aaron Mendelsohn, Director | ||
| Robert Greenberg, President CEO, Director | ||
| Matthew Pfeffer, Independent Director |
Second Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Second Sight in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Second Sight's short interest history, or implied volatility extrapolated from Second Sight options trading.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.65 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
| 0.72 | JPHLF | Japan Post Holdings | PairCorr |
| 0.71 | MZHOF | Mizuho Financial | PairCorr |
| 0.67 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.59 | ALGN | Align Technology Earnings Call This Week | PairCorr |
| 0.59 | SMFNF | Sumitomo Mitsui Financial | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |